Your browser doesn't support javascript.
loading
Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibro-stenosis in Crohn's disease.
Ke, Bo-Jun; Abdurahiman, Saeed; Biscu, Francesca; Zanella, Gaia; Dragoni, Gabriele; Santhosh, Sneha; De Simone, Veronica; Zouzaf, Anissa; van Baarle, Lies; Stakenborg, Michelle; Bosáková, Veronika; Van Rymenant, Yentl; Verhulst, Emile; Verstockt, Sare; Klein, Elliott; Bislenghi, Gabriele; Wolthuis, Albert M; Fric, Jan; Breynaert, Christine; D'Hoore, Andre; Van der Veken, Pieter; De Meester, Ingrid; Lovisa, Sara; Hawinkels, Lukas Jac; Verstockt, Bram; De Hertogh, Gert; Vermeire, Séverine; Matteoli, Gianluca.
Afiliación
  • Ke BJ; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • Abdurahiman S; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • Biscu F; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • Zanella G; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • Dragoni G; Gastroenterology Research Unit, Department of Experimental and Clinical Bio, University of Florence, Florence, Italy.
  • Santhosh S; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • De Simone V; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • Zouzaf A; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • van Baarle L; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • Stakenborg M; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • Bosáková V; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
  • Van Rymenant Y; Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
  • Verhulst E; Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
  • Verstockt S; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
  • Klein E; Department of Immunology and Respiratory Research, Boehringer Ingelheim Pharmaceuticals, Inc., United States of America.
  • Bislenghi G; Department of Abdominal Surgery, UZ Leuven, Leuven, Belgium.
  • Wolthuis AM; Department of Abdominal Surgery, UZ Leuven, Leuven, Belgium.
  • Fric J; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
  • Breynaert C; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • D'Hoore A; Department of Abdominal Surgery, UZ Leuven, Leuven, Belgium.
  • Van der Veken P; Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
  • De Meester I; Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
  • Lovisa S; Department of Biomedical Sciences, Humanitas University, United States of America.
  • Hawinkels LJ; Department of Gastroenterology-Hepatology, Leiden University Medical Center, Leiden, Netherlands.
  • Verstockt B; Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.
  • De Hertogh G; Laboratory of Pathology, UZ Leuven, Leuven, Belgium.
  • Vermeire S; Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.
  • Matteoli G; CHROMETA - TARGID, KU Leuven, Leuven, Belgium.
J Clin Invest ; 2024 Jul 23.
Article en En | MEDLINE | ID: mdl-39042469
ABSTRACT
Crohn's disease (CD) is marked by recurring intestinal inflammation and tissue injury, often resulting in fibro-stenosis and bowel obstruction, necessitating surgical intervention with high recurrence rates. To elucidate to the mechanisms underlying fibro-stenosis in CD, we analysed the transcriptome of cells isolated from the transmural ileum of CD patients, including a trio of lesions from each patient non-affected, inflamed, and stenotic ileum samples, and compared them with samples from non-CD patients. Our computational analysis revealed that pro-fibrotic signals from a subset of monocyte-derived cells expressing CD150 induced a disease-specific fibroblast population, resulting in chronic inflammation and tissue fibrosis. The transcription factor TWIST1 was identified as a key modulator of fibroblast activation and extracellular matrix (ECM) deposition. Genetic and pharmacological inhibition of TWIST1 prevents fibroblast activation, reducing ECM production and collagen deposition. Our findings suggest that the myeloid-stromal axis may offer a promising therapeutic target to prevent fibro-stenosis in CD.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Invest Año: 2024 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Invest Año: 2024 Tipo del documento: Article País de afiliación: Bélgica